Percutaneous microwave ablation of renal masses in a UK cohort.
Joseph B JohnMoira AndersonThomas DuttonMark StottMalcolm CrundwellRhys LlewelynAndrew GemmellRory BufacchiAlexander SpiersNicholas CampainPublished in: BJU international (2020)
We describe the largest UK series of MWA treatment for T1a/small T1b renal masses to date. MWA was well tolerated, with 95% discharged the following day and low complication/re-admission rates. Current follow-up demonstrates favourable disease control. MWA appears to be safe and effective and should be considered in future prospective comparisons of treatments for T1a/small T1b renal masses.